Incentivizing New Veterinary Pharmaceutical Products to Combat Antibiotic Resistance

Stacy Sneeringer and Matthew Clancy

Applied Economic Perspectives and Policy, 2020, vol. 42, issue 4, 653-673

Abstract: The development of alternative animal health products is one way to reduce antibiotic use in agriculture. However, little economic research is directed at animal pharma. While programs to incentivize research and development (R&D) for human drugs have been adopted, analogous programs in veterinary pharma are only at the proposal stage. We describe the broad “push” and “pull” incentive mechanisms for human pharma, and analyze the differences in employing these in veterinary pharma. Using newly compiled data on veterinary drug approvals and firm‐level R&D, we also present data on trends in drug development for veterinary pharma.

Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://doi.org/10.1093/aepp/ppz022

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wly:apecpp:v:42:y:2020:i:4:p:653-673

Access Statistics for this article

More articles in Applied Economic Perspectives and Policy from John Wiley & Sons
Bibliographic data for series maintained by Wiley Content Delivery ().